24-Hour Induction of Transdermal Buprenorphine to Buprenorphine Extended-Release.  Azar P, Li VW, Wong JSH, Nikoo M, Machado J, Ignaszewski MJ, Mathew N, Raheemullah A, Wakeman SE, Mullen R, Krausz RM, Montaner JSG, Maharaj AR.  J Psyc...

Buprenorphine Salivary Gland Accumulation Sustaining High Oral Fluid Exposure and Increasing the Risk of Streptococcus mutans Biofilm Formation.  Zheng Z, Chen J, Srinual S, Tumbas Šaponjac V, Yin T, Wang BY, Sun R, Hu M.  J Addict Med...

Buprenorphine initiation and rates of associated precipitated withdrawal in patients with fentanyl use in an urban emergency department.  Checkley L, Ly J, Geier C, LeSaint KT.  Am J Emerg Med. 2024 Nov 25;88:152-155. doi: 10.1016/j.aj...

Impact of Alternative Ways to Operationalize Buprenorphine Treatment Duration on Understanding Continuity of Care for Opioid Use Disorder.  Dong H, Stringfellow EJ, Russell WA, Bearnot B, Jalali MS.  Int J Ment Health Addict. 2024 Aug;...

Buprenorphine 'microdosing' method for switching patients with opioid dependence from methadone to buprenorphine.  Singh YC, Singh S, Bhad R, Rao R.  BMJ Case Rep. 2024 Nov 7;17(11):e259716. doi: 10.1136/bcr-2024-259716. PMID: 39510616...

Buprenorphine-Naloxone for Opioid Use Disorder: Reduction in Mortality and Increased Remission.  Paul KK, Frey CG, Troung S, Paglicawan LVQ, Cunningham KA, Preston Hill T, Bothwell LG, Golovko G, Pillay Y, Jehle D.  West J Emerg Med. 2...